OncoVista Innovative Therapies, Inc. Stock Other OTC
Equities
OVIT
US68232J1051
Biotechnology & Medical Research
Financials (USD)
Sales 2013 | - | Sales 2014 | - | Capitalization | 1.3M |
---|---|---|---|---|---|
Net income 2013 | -1M | Net income 2014 | -2M | EV / Sales 2013 | - |
Net cash position 2013 | 44.9K | Net Debt 2014 | 196K | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.75
x | P/E ratio 2014 |
-0.51
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
1st Jan change | Capi. | |
---|---|---|
+3.62% | 43.43B | |
+47.81% | 41.69B | |
+9.08% | 41.31B | |
-10.92% | 27.14B | |
+8.79% | 25.28B | |
-25.02% | 18.47B | |
+29.35% | 12.59B | |
+0.76% | 12.33B | |
+8.60% | 11.03B |